📰 V Wave Ltd News
V Wave Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from V Wave Ltd. Real-time updates on events, politics, business and more.
April 6, 2024
For an all-comer population with any impairment of LV function, an interarterial shunt device missed the primary endpoint in RELIEVE-HF, but benefit was seen with LVEF less than 40%.
March 28, 2024
/PRNewswire/ -- V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiologys (ACC)...
October 24, 2022
/PRNewswire/ -- V-Wave, announced today the completion of enrollment in RELIEVE-HF, a prospective, randomized, double-blinded, sham-controlled, multi-center...
December 16, 2021
/PRNewswire/ -- V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with...
December 16, 2021
/PRNewswire/ -- V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with...
February 17, 2021
scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors February 17, 2021 08:00 ET | Source: scPharmaceuticals, Inc. scPharmaceuticals, Inc. Burlington, Massachusetts, UNITED STATES BURLINGTON, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the d...